2021 will be the year of Medmira!...........................The new associated test is a huge opportunity for Medmira -and therefore also for all shareholders who hold there shares. What nice is -- we can see very positively in the coming first quarter of 2021 with the last two reports from 2020. From this perspective the current course is not relevant for me. Hold on ... it will be worth it !!